U.S. flag

An official website of the United States government

GTR Home > Laboratories > Secugen SL

Secugen SL

GTR Lab ID: 320355, Last updated:2023-08-07

Personnel

  • Director: Jesus ViƱas Lopez, MD, Laboratory responsible
    Phone: 00-34-91-8046601
    Email: j.vinas@secugen.es
  • Director: Julian Perez Perez, PhD, Lab Director
    Phone: +34 918063105
    Email: j.perez@secugen.es

Conditions and tests

  • Aicardi-Goutieres syndrome 11 test
  • Alzheimer disease 31 test
  • Alzheimer disease 42 tests
  • Alzheimer disease type 11 test
  • Amyotrophic lateral sclerosis type 61 test
  • Atypical hemolytic-uremic syndrome with B factor anomaly3 tests
  • Atypical hemolytic-uremic syndrome with C3 anomaly3 tests
  • Atypical hemolytic-uremic syndrome with I factor anomaly3 tests
  • Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly3 tests
  • Atypical hemolytic-uremic syndrome with thrombomodulin anomaly3 tests
  • Brugada syndrome 51 test
  • Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 11 test
  • Developmental and epileptic encephalopathy, 91 test
  • Frontotemporal dementia and/or amyotrophic lateral sclerosis 11 test
  • Frontotemporal dementia and/or amyotrophic lateral sclerosis 61 test
  • GRN-related frontotemporal lobar degeneration with Tdp43 inclusions1 test
  • Hemolytic uremic syndrome, atypical, childhood2 tests
  • Hemolytic uremic syndrome, atypical, susceptibility to2 tests
  • Hemolytic uremic syndrome, atypical, susceptibility to, 110 tests
  • Hemolytic-uremic syndrome1 test
  • Marfan syndrome1 test
  • Progressive supranuclear ophthalmoplegia1 test
  • Severe myoclonic epilepsy in infancy2 tests
  • TARDBP-related frontotemporal dementia1 test
  • Telangiectasia, hereditary hemorrhagic, type 11 test
  • Telangiectasia, hereditary hemorrhagic, type 21 test
  • Upshaw-Schulman syndrome1 test

List of services

  • Clinical Testing/Confirmation of Mutations Identified Previously

List of certifications/licenses

Certifications

  • Standardization ISO 9001:2015, Number: ES125938-1, Expiration date: 2024-12-21

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.